EMEA-000365-PIP01-08-M12
Key facts
| Invented name |
Tamiflu
|
| Active substance |
Oseltamivir (phosphate)
|
| Therapeutic area |
Infectious diseases
|
| Decision number |
P/0241/2021
|
| PIP number |
EMEA-000365-PIP01-08-M12
|
| Pharmaceutical form(s) |
|
| Condition(s) / indication(s) |
Treatment and prevention of influenza
|
| Route(s) of administration |
Oral use
|
| Contact for public enquiries |
Roche Registration GmbH
E-mail: info.paediatrics@roche.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-000365-PIP01-08-M12
|
| Compliance opinion date |
15/10/2021
|
| Compliance outcome |
positive
|